Keyphrases
In Situ Hybridization
100%
Immunoelectron Microscopy
93%
Electron Microscopic
93%
Drosophila Ovary
93%
LncRNA NEAT1
46%
MiRNA Biogenesis
46%
Precise Location
46%
Japan
46%
Myositis
46%
Very Old
46%
Ovarian Somatic Cells
46%
Nivolumab
46%
Community-dwelling
46%
Well-being
46%
Biological Applications
46%
Neurogenic Pulmonary Edema
46%
Life Satisfaction
46%
Comorbidity
46%
Aging
46%
A-to-I Editing
46%
ADAR1
46%
Paraspeckles
46%
Long Non-coding RNA nuclear-enriched Abundant Transcript 1
46%
RNA-editing Enzymes
46%
Neuro-diseases
46%
PIWI-interacting RNA (piRNA)
46%
Amyloid PET
46%
Self-rated Health
46%
Health Satisfaction
46%
H2N2
46%
Longitudinal Cohort
46%
Cadherin-7
46%
Gold Particles
46%
Biogenesis
46%
Patients with multimorbidity
46%
Kawasaki
46%
Cohort Analysis
46%
Drosophilidae
46%
Human Primates
46%
Subcellular Localization
46%
Myasthenia Gravis
46%
Inclusion Bodies
46%
Older Persons
46%
Rodents
46%
Multimorbid
46%
Adenosine Deaminase Acting on RNA
38%
Pontine nuclei
37%
Specificity Protein 1
23%
Uorescence
23%
Immune Checkpoint Inhibitors
23%
Biochemistry, Genetics and Molecular Biology
Intravenous Immunoglobulin
93%
Electron Microscopy
93%
in Situ Hybridization
93%
Long Non-Coding RNA
93%
Piwi-Interacting RNA
93%
Biogenesis
93%
RNA
93%
Motor Neuron
80%
Induced Pluripotent Stem Cell
56%
Serine Protease
46%
Autosomal Recessive Inheritance
46%
Testosterone Blood Level
46%
Paraspeckle
46%
Apolipoprotein
46%
RNA Editing
46%
Adenosine Deaminase Acting Rna
46%
Subcellular Localization
46%
Somatic Cell
46%
Nucleoporin
46%
FUS
46%
Nuclear Lamina
46%
Allele
33%
C9orf72
31%
Animal Model
24%
Stress Granule
18%
Cell Death
15%
TAR DNA Binding Protein
15%
Precursor
15%
RNA-binding Protein
15%
Overall Survival
15%
E-Site
15%
Kv1.1
15%
Computational Genomics
15%
Non-Coding RNA
15%
Protein Repeat
15%
Dipeptide
15%
Caspase 3
15%
Lower Motor Neuron
14%
Mortality Rate
12%
Missense Mutation
12%
Fusion Gene
9%
Genetic Regulation
9%
Stem Cell Line
9%
Protein Sequencing
9%
Mouse Model
9%
Alternative Splicing
9%
Nuclear Localization Sequence
9%
CRISPR/Cas9
9%
Transfer RNA
9%
Genetic Approach
9%
Medicine and Dentistry
RNA Editing
93%
Multiple Chronic Conditions
93%
Wellbeing
56%
Magnetic Resonance Imaging
53%
Cross Sectional Study
52%
Myositis
46%
Cell Line
46%
Nivolumab
46%
Amyloid
46%
Positron Emission Tomography
46%
Cohort Analysis
46%
Adenosine Deaminase
46%
Dural Arteriovenous Fistula
46%
Enzyme Defect
46%
Amyotrophic Lateral Sclerosis
46%
Self Rated Health
46%
ADAR
46%
Myasthenia gravis
46%
Respiratory Distress
46%
Corpus Callosum
46%
Splenium
46%
Cell Culture
46%
Tau
46%
Patient Care
46%
Bleeding
46%
Health Care Cost
28%
Polypharmacy
28%
Messenger RNA Precursor
28%
Symptom
24%
Immune Checkpoint Inhibitor
23%
Kv1.1
23%
Pulmonary Edema
23%
Mild Cognitive Impairment
18%
Outpatient
18%
Weakness
18%
Medulla Oblongata
18%
Arthritis
17%
Prevalence
15%
Involuntary Movement
13%
Immunoglobulin
11%
Plasma Exchange
11%
Dyspnea
11%
Cerebrovascular Disease
11%
Tracheal Intubation
11%
Noninvasive Positive Pressure Ventilation
11%
Prednisolone
11%
Programmed Death 1 Receptor
11%
Limb
11%
Monoclonal Antibody
11%
Myalgia
11%